MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Monitor Can Diagnose Asymptomatic Atrial Fibrillation

The Houston Chronicle reports that ECardio Diagnostics LLC has launched its eTrigger AF920 event monitor for detection of atrial fibrillation among asymptomatic patients. Unlike standard cardiac monitoring devices, this monitor automatically detects and records asymptomatic events without the patient having to activate it.

This feature is key to diagnosing atrial fibrillation, because as the name suggests, patients often don't feel symptoms during an episode. Atrial fibrillation is the most common sustained heart rhythm disorder, and it increases the risk for heart disease and stroke. An estimated 2.2 million adults in the United States have been diagnosed with it, and that number is expected to increase to more than 5 million by 2040. Devices that treat patients who don't even feel sickâEUR"that is a real example of innovation and serving an unmet need in the market.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.